Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.
This report contains market size and forecasts of Transmucosal Drug Delivery Devices in global, including the following market information:
Global Transmucosal Drug Delivery Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Transmucosal Drug Delivery Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Transmucosal Drug Delivery Devices companies in 2021 (%)
The global Transmucosal Drug Delivery Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Buccal Route Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transmucosal Drug Delivery Devices include Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd and Callitas Therapeutics Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transmucosal Drug Delivery Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transmucosal Drug Delivery Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transmucosal Drug Delivery Devices Market Segment Percentages, by Type, 2021 (%)
Buccal Route
Rectal Route
Nasal Route
Global Transmucosal Drug Delivery Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transmucosal Drug Delivery Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Residential
Global Transmucosal Drug Delivery Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transmucosal Drug Delivery Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transmucosal Drug Delivery Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Transmucosal Drug Delivery Devices revenues share in global market, 2021 (%)
Key companies Transmucosal Drug Delivery Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Transmucosal Drug Delivery Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals
Combinent BioMedical Systems Inc
Aegis Therapeutics LLC
Bespak Europe Ltd
Callitas Therapeutics Inc